tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Holding ALGS?
Track your performance easily

Aligos Therapeutics (ALGS) Financial Statements

163 Followers

Aligos Therapeutics Financial Overview

Aligos Therapeutics's market cap is currently ―. The company's EPS TTM is $-13.346; its P/E ratio is -2.99; Aligos Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-2.50. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.25M$ 1.06M$ 694.00K$ 2.68M$ 3.24M
Gross Profit$ 1.25M$ 1.06M$ 694.00K$ -1.92M$ 1.08M
EBIT$ -19.67M$ -26.41M$ -35.44M$ -26.00M$ -19.07M
EBITDA$ -18.95M$ -25.80M$ -34.83M$ -25.22M$ -18.39M
Net Income Common Stockholders$ -19.26M$ 5.06M$ -34.86M$ -27.89M$ -18.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 74.92M$ 94.54M$ 112.74M$ 135.70M$ 70.43M
Total Assets$ 88.43M$ 108.81M$ 127.90M$ 151.53M$ 85.85M
Total Debt$ 9.13M$ 9.84M$ 10.48M$ 11.14M$ 11.77M
Net Debt$ -65.79M$ -84.70M$ -102.25M$ -124.57M$ -58.66M
Total Liabilities$ 38.33M$ 41.58M$ 68.11M$ 59.45M$ 31.03M
Stockholders Equity$ 50.10M$ 67.23M$ 59.80M$ 92.08M$ 54.82M
Cash Flow-
Free Cash Flow$ -20.10M$ -19.49M$ -22.75M$ -22.66M$ -20.35M
Operating Cash Flow$ -20.10M$ -19.49M$ -22.75M$ -22.66M$ -20.34M
Investing Cash Flow$ 10.40M$ 39.99M$ -88.64M$ -7.00K$ -9.00K
Financing Cash Flow$ -4.00K$ 281.00K$ -19.00K$ 87.94M$ -21.00K
Currency in USD

Aligos Therapeutics Earnings and Revenue History

Aligos Therapeutics Debt to Assets

Aligos Therapeutics Cash Flow

Aligos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis